Mercodia webinars connect you with experts in various scientific fields. These special sessions are educational, informative and often provide you with answers to questions that may assist your group in making decisions now or in the future. All of our webinars are recorded and posted below as an added resource for our valued customers.
12. NAFLD & NASH: Links to Obesity & Diabetes: Dr. Kenneth Cusi (University of Florida)
RECORDING COMING SOON!
NAFLD is characterized by increased fat accumulation in the liver, and in the case of NASH, can lead to liver damage. Uncovering metabolic causes & consequences of NAFLD is key to understanding the etiology and treatment of this disease.
During this webinar, one of the foremost experts will discuss the pathophysiology of NAFLD, with particular focus on links to obesity and diabetes.
11. GLP-1 Secretion in Humans: Recent Advances: Dr. Jens Juul Holst
There is no doubt that gut hormones play an important role in human physiology. Perhaps the most famous of these hormones is the incretin GLP-1. During this webinar, one of the foremost experts on GLP-1 will focus on how the secretion of this gut hormone is regulated, including well-established and novel pathways.
10. Insulin and Glucagon Regulation in Health & Disease: Dr. Patrik Rorsman
Insulin and glucagon work in concert to modulate blood glucose levels. The release of these hormones, from pancreatic islets, is a highly regulated process that involves complex pathways.
During this webinar, a leading expert will present data on precise mechanisms regulating the secretion of these two hormones under normal conditions. He will also discuss how these pathways go awry during diabetes and how they may be targeted by therapeutic strategies.
9. Metabolic & Cardiovascular Complications of HIV: Dr. Grace McComsey
Millions of people, worldwide, are living with HIV. Common co-morbidities of this disease include lipodystrophy and premature atherosclerosis. The metabolic and cardiovascular complications associated with HIV have become of increasing importance for understanding pathogenesis of HIV and how these complications may be contributing to the persistent state of immune activation in HIV despite successful treatment. During this webinar, a world-renowned expert will present on the current understanding of these complications in HIV-infected adults.
8. Obesity, Adiponectin and Cancer: Dr. Christos Mantzoros
Excess body weight is associated with an increased risk for a number of cancers. Adiponectin is an important adipokine that has been shown to have antiproliferative and proapoptotic properties. In addition, levels of adiponectin have been inversely associated with cancer risk.
During this webinar, a leading expert will discuss scientific evidence connecting adiponectin and cancer risk.
7. Bariatric Surgery: Regulation of Gut and Islet Hormones - Dr. David A. D’Alessio
*QuickTime may not play this file appropriately. If you have trouble viewing this recording, click here to download a free VLC player.
Click here to learn about the distinguished speaker
Bariatric surgery is proven to be highly effective for the treatment of obesity. These procedures not only affect hormones in the gut but have an impact on islet hormones that regulate glucose metabolism.
Dr. D’Alessio is a highly regarded physician and scientist, who is known for his expertise in the field of endocrinology. During this webinar, he discusses the impact of bariatric surgery on incretins (e.g., GLP-1) and islet hormones (e.g., insulin and glucagon).
6. Leptin and Diabetes - Dr. Jeffrey M. Friedman and Dr. Roger Unger
Leptin is an important hormone secreted by adipose tissue. It plays a critical role in a number of processes including energy regulation.
During this webinar, two leading expert scientists discuss how leptin is connected to type 1 and type 2 diabetes, including a link to glucagon.
5. Beta Cell Regeneration: Novel Sources - Dr. Juan Domínguez-Bendala and Dr. Pedro Herrera
The loss of functional beta cells underlies the pathology of diabetes and has serious metabolic consequences in these patients. Thus, scientists are examining ways to replace these critical endocrine cells.
During this webinar, two expert scientists discuss regeneration of pancreatic beta cells from stem cells, exocrine cells and alpha cells.
4. Advances in the Bionic Pancreas - Dr. Steven Russell
The management of type 1 diabetes mellitus (T1DM) has often been referred to as a “second job” for those with the disease. The need for close and careful glucose monitoring, multiple daily insulin injections as well as dangerous and sometimes fatal hypoglycemia has led researchers to develop a bihormonal (i.e., insulin & glucagon) bionic pancreas. During this webinar, Dr. Steven Russell discusses the advances that have been made in this project.
Dr. Russell is a clinician and scientist who is world-renowned for his work on therapies for T1DM, particularly theBionic Pancreas Project, of which he is a Principal Investigator.
Visit our podcast webpage to listen to a short interview with one of the bionic pancreas clinical trial participants.
3. Glucagon Release with SGLT2 Inhibition - Dr. Ralph DeFronzo
Increased glucose excretion through SGLT2 inhibition is a new mode of treatment for type 2 diabetes mellitus (T2DM). During this webinar, Dr. DeFronzo presents intriguing results showing a paradoxical increase in glucagon and endogenous glucose production with SGLT2 inhibition.
Dr. DeFronzo is a world-renowned clinician and researcher, who has helped define the biochemical and molecular disturbances responsible for insulin resistance in T2DM.
2. Glucagon - A Therapeutic Target - Dr. Alan D Cherrington
Glucagon is an important therapeutic target for multiple metabolic diseases. During this webinar, Dr. Cherrington provides insight into ways to target this glucose regulator.
Dr. Cherrington is world-renowned for his contributions to the understanding of how the liver is regulated, by various hormones and neural mediators, to release or store glucose, depending on a variety of physiological conditions.
1. Glucagon & Glicentin: Unique hormones from the Same Precursor - Dr. Jens Juul Holst
Glucagon and Glicentin are both made from proglucagon but these two hormones are unique in multiple ways. During this webinar, Dr. Holst discusses their physiological roles and technical challenges associated with the measurement of these biomarkers.
Dr. Holst is a world-renowned expert in the diabetes and obesity fields, and his accomplishments include the isolation and characterization of GLP-1.